Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Eisai
|
| gptkbp:acquisition |
Acquired by a private equity firm in 2021
|
| gptkbp:ceo |
gptkb:Vincent_J._Angotti
|
| gptkbp:clinical_trial |
Phase 1 trials for ARX-03
Phase 2 trials for ARX-04 Phase 3 trials for DSUVIA completed studies for DSUVIA ongoing studies for Zalviso studies for ARX-01 dosage studies for ARX-02 effectiveness studies for ARX-03 safety studies for ARX-04 efficacy studies for opioid-sparing strategies studies for pain management efficacy conducts clinical research for pain management solutions |
| gptkbp:employees |
approximately 50
|
| gptkbp:financial_products |
funding rounds completed
investments received operating loss in 2022 reported revenue in 2022 |
| gptkbp:focus |
pain management
|
| gptkbp:founded |
gptkb:2006
|
| gptkbp:founder |
gptkb:Vincent_J._Angotti
|
| gptkbp:headcount |
increased in recent years
|
| gptkbp:headquarters |
gptkb:Redwood_City,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Acel Rx Pharmaceuticals
|
| gptkbp:investment |
international markets
various institutional investors U. S. market |
| gptkbp:market_cap |
approximately $100 million
|
| gptkbp:partnership |
gptkb:Abb_Vie
collaborates with research institutions collaborates with healthcare providers works with pain management specialists |
| gptkbp:products |
gptkb:ARX-01
gptkb:ARX-02 gptkb:ARX-03 gptkb:ARX-04 gptkb:DSUVIA gptkb:Zalviso ARX-01 for postoperative pain ARX-01 for postoperative recovery. ARX-02 for breakthrough pain ARX-02 for severe breakthrough pain ARX-03 for chronic pain ARX-03 for moderate pain management ARX-04 for acute pain ARX-04 for severe pain management DSUVIA for emergency settings DSUVIA for sublingual use Zalviso for hospital use Zalviso for patient-controlled analgesia |
| gptkbp:regulatory_compliance |
European Medicines Agency approval for DSUVIA
FDA approval for DSUVIA |
| gptkbp:research_focus |
opioid alternatives
|
| gptkbp:symbol |
ACRX
|
| gptkbp:traded_on |
gptkb:NASDAQ
|
| gptkbp:website |
www.acelrx.com
|